{
  "@context": {
    "biotools": "https://bio.tools/ontology/",
    "bsc": "http://bioschemas.org/",
    "bsct": "http://bioschemas.org/types/",
    "dct": "http://purl.org/dc/terms/",
    "edam": "http://edamontology.org/",
    "owl": "http://www.w3.org/2002/07/owl#",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://bio.tools/atlantic",
      "@type": "sc:SoftwareApplication",
      "dct:conformsTo": "https://bioschemas.org/profiles/ComputationalTool/0.6-DRAFT",
      "sc:additionalType": "Web application",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_0080"
        },
        {
          "@id": "edam:topic_0121"
        },
        {
          "@id": "edam:topic_0154"
        },
        {
          "@id": "edam:topic_2640"
        },
        {
          "@id": "edam:topic_3308"
        },
        {
          "@id": "edam:topic_3336"
        }
      ],
      "sc:citation": [
        {
          "@id": "https://doi.org/10.1038/S41467-020-17336-9"
        },
        "pubmed:32686665",
        "pmcid:PMC7371697"
      ],
      "sc:description": "Proteome activity landscapes of tumor cell lines determine drug responses.\n\nIntegrated analysis of genomes, transcriptomes, proteomes and drug responses of cancer cell lines (CCLs) is an emerging approach to uncover molecular mechanisms of drug action.",
      "sc:featureList": [
        {
          "@id": "edam:operation_0417"
        },
        {
          "@id": "edam:operation_3799"
        }
      ],
      "sc:license": "Apache-2.0",
      "sc:name": "ATLANTiC",
      "sc:url": "http://atlantic.proteomics.wzw.tum.de/"
    },
    {
      "@id": "https://doi.org/10.1038/S41467-020-17336-9",
      "@type": "sc:CreativeWork"
    }
  ]
}